SG3 Management’s Medtronic MDT Stock Holding History

SG3 Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-25,000	Closed	-$2.77M	–	652
2022 Q1	$2.77M	Buy	+25,000	New	+$2.64M	0.08%	237
2021 Q2	–	Sell	-800	Closed	-$95K	–	1199
2021 Q1	$95K	Sell	800 -15,700	-95%	-$1.84M	﹤0.01%	1053
2020 Q4	$1.93M	Buy	+16,500	New	+$1.82M	0.04%	392
2020 Q2	–	Sell	-1,500	Closed	-$135K	–	676
2020 Q1	$135K	Buy	+1,500	New	+$160K	0.02%	279

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SG3 Management's MDT Position: Q2 2022 in Review

SG3 Management sold out of Medtronic (MDT) in Q2 2022, closing a stake of 25,000 shares — an estimated $2.77M sold.

SG3 Management first reported a position in MDT in Q1 2020 and held it in 4 quarters. The position peaked at $2.77M in Q1 2022. 2,023 funds tracked by Wall St. Rank hold MDT as of Q2 2022.

SG3 Management reported no remaining Medtronic position as of Q2 2022 after selling out during the quarter.
SG3 Management sold 25,000 Medtronic shares in Q2 2022, an estimated $2.77M.
SG3 Management first reported a position in Medtronic in Q1 2020 and held it in 4 quarters.
SG3 Management's Medtronic position peaked at $2.77M in Q1 2022.
2,023 funds tracked by Wall St. Rank held Medtronic as of Q2 2022.

Based on SG3 Management's 13F filing for Q2 2022, filed 15 Aug 2022.